Monday, January 25, 2021 7:00:51 PM
RLF owns the RLF-100* patent for formulations in the US and several other countries. India is usually an outsider itself and manufactured Remdesivir without license for use in their own country. Currently there is plenty of demand in the countries the patent protection includes.
ACER is perfect for RLF. It would get us out from under the NRX thumb and their issues. The recent new hires at RLf seems to prove JB's point that this is not an unplanned fling and that there are many possibilities that can happen beyond the basic agreement.
Ruf, I hope you know that Aviptadil was an ED drug before repurposing for COVID/lung issues, so why not the drug from Acer that is for a urinary issue too?
*(by whever brand name)
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM